| Literature DB >> 23029373 |
Franco Valenza1, Marta Pizzocri, Valentina Salice, Giorgio Chevallard, Tommaso Fossali, Silvia Coppola, Sara Froio, Federico Polli, Stefano Gatti, Francesco Fortunato, Giacomo P Comi, Luciano Gattinoni.
Abstract
INTRODUCTION: Lactic acidosis is a frequent cause of poor outcome in the intensive care settings. We set up an experimental model of lactic acid infusion in normoxic and normotensive rats to investigate the systemic effects of lactic acidemia per se without the confounding factor of an underlying organic cause of acidosis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23029373 PMCID: PMC3461035 DOI: 10.1371/journal.pone.0046035
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Protocol overview.
A schematic overview of the experiment flow is shown in the figure. The investigation consisted of an initial lactic acid load to induce lactic acidemia followed by randomization to sustained (S) or transient (T) lactic acid infusion with or without sodium bicarbonate (B) treatment.
Figure 2Lactate over time in the four groups.
Lactic acid load caused blood lactate to rise in all groups (# P<0.05 vs. time 0). After 135 minutes in the sustained groups blood lactate remained high both in the sustained (S) and the sustained+NaHCO3 (S+B) group. In the transient (T) groups blood lactate levels after 135 minutes were different from values at time 75 minutes (° P<0.05). Animals that received NaHCO3 (T+B) had higher lactate levels (* P<0.05 vs. transient group).
Figure 3Blood pH over time in the four groups.
After 75 minutes of infusion of lactic acid blood pH drop in all groups (# P<0.05 vs. time 0). At 135 minutes pH normalized in the transient group (T) while overshoot to alkalemic values when animals received NaHCO3 (T+B). In the sustained group (S) pH continued to drop while alkaline infusion (S+B) resulted in correction of acidosis. ° P<0.05 vs time 75; * P<0.05 vs. control.
Acid base variables and plasma chemistry.
| Min | S |
| T |
| |
|
| 0 | 7.42±0.01 | 7.42±0.01 | 7.43±0.01 | 7.43±0.01 |
| 75 | 7.22±0.02 | 7.22±0.02 | 7.23±0.02 | 7.24±0.01 | |
| 135 | 7.13±0.05 | 7.36±0.04 | 7.36±0.02 | 7.53±0.03 | |
|
| 0 | 40±1.1 | 39±0.9 | 42±1.3 | 40±1.1 |
| 75 | 55±3 | 49±2.4 | 55±2.9 | 47±3.4 | |
| 135 | 56±4.9 | 55±4.6 | 46±2.8 | 49±4.9 | |
|
| 0 | 26.2±0.9 | 25.3±1 | 27.5±1 | 26.9±0.8 |
| 75 | 22.7±1.6 | 19.9±1 | 22.8±1.4 | 20.0±1.6 | |
| 135 | 19.3±2.6 | 31.8±4.1 | 25.9±1.5 | 40.5±3 | |
|
| 0 | 1.7±1.1 | 0.8±1.1 | 3.2±1.1 | 2.6±0.9 |
| 75 | −5±1.9 | −7.9±1.1 | −4.8±1.6 | −7.3±1.7 | |
| 135 | −10.2±3.5 | 6.3±4.7 | 0.5±1.6 | 17.4±2.7 | |
|
| 0 | 1.2±0.2 | 1.1±0.1 | 1.3±0.1 | 1.3±0.1 |
| 75 | 5.4±0.5 | 6±0.5 | 5.5±0.4 | 5±0.5 | |
| 135 | 7.4±1.6 | 8±1.5 | 1±0.2 | 2.9±1 | |
|
| 0 | 136.2±3.8 | 138.8±2.5 | 137.9±1.3 | 135±1.5 |
| 75 | 132.4±2.8 | 136.2±3.3 | 138.2±1.5 | 137.5±1.1 | |
| 135 | 135.3±1.9 | 144.3±1.1 | 136.4±1.7 | 147.8±1.2 | |
|
| 0 | 4.26±0.16 | 3.64±0.09 | 3.94±0.17 | 3.86±0.17 |
| 75 | 4.36±0.16 | 3.75±0.2 | 4.18±0.25 | 3.9±0.25 | |
| 135 | 4.73±0.31 | 3.95±0.45 | 4.8±0.42 | 4.36±0.31 | |
|
| 0 | 105.3±2.4 | 109.0±0.7 | 105.8±0.7 | 108.0±0.9 |
| 75 | 110.7±2.3 | 112.5±1.2 | 113.2±1.6 | 112.3±1 | |
| 135 | 110.6±3 | 112.0±1.5 | 112.6±0.8 | 107.3±1.8 | |
|
| 0 | 31.5±1.1 | 31.5±0.8 | 33.4±1.1 | 30.8±1.1 |
| 75 | 27.1±2.2 | 23.2±1.4 | 25.5±2.6 | 25.7±0.5 | |
| 135 | 29.8±2 | 30.9±3 | 32.2±0.8 | 43.4±1.8 | |
|
| 0 | 0.94±0.13 | 0.99±0.1 | 0.98±0.07 | 0.99±0.07 |
| 75 | 0.93±0.13 | 1.07±0.09 | 1.06±0.06 | 1.08±0.06 | |
| 135 | 1.02±0.08 | 0.97±0.11 | 0.96±0.07 | 0.85±0.07 | |
|
| 0 | 165±18 | 153±13 | 149±8 | 160±17 |
| 75 | 125±6 | 116±10 | 120±7 | 112±8 | |
| 135 | 116±15 | 117±12 | 112±6 | 79±13 | |
|
| 0 | 13.4±0.6 | 14±0.8 | 13.4±0.5 | 13.3±0.4 |
| 75 | 10.9±0.7 | 11.1±0.8 | 10.8±0.7 | 10.8±0.6 | |
| 135 | 7.7±0.5 | 8.7±1.4 | 9.9±0.4 | 9.1±0.5 |
ANOVA P<0.05:
vs. 0,
vs. 75,
S vs. S+B or T vs. T+B.
BE, base excess; Lac, lactate concentration; Na, sodium concentration; K, potassium concentration; Cl, chloride concentration; SIDa, stron ion difference; iCa, ionized calcium concentration; Glc, glycemia; Hb, hemoglobin concentration.
Data are expressed as mean ± SEM.
Hemodynamic and respiratory variables.
| min | S |
| T |
| |
|
| 0 | 134±6.8 | 132±3.92 | 134±7.51 | 133±4.76 |
| 75 | 140±5.6 | 131±5.59 | 134±6.96 | 139±5.85 | |
| 135 | 108±11.96 | 103±17.13 | 119±7.29 | 113±10.73 | |
|
| 0 | 417±20.77 | 460±13.55 | 439±12.21 | 417±15.88 |
| 75 | 382±10.84 | 390±19.82 | 389±5.9 | 368±15.18 | |
| 135 | 351±22.03 | 404±8.7 | 394±18.73 | 397±21.99 | |
|
| 0 | 2.81±0.14 | 3.03±0.19 | 2.78±0.12 | 3.03±0.08 |
| 75 | 2.81±0.14 | 3.03±0.19 | 2.78±0.12 | 3.03±0.08 | |
| 135 | 2.81±0.16 | 3.03±0.25 | 2.78±0.12 | 3.03±0.08 | |
|
| 0 | 72±2.1 | 64±3.8 | 70±1.6 | 69±2.7 |
| 75 | 71±2.2 | 64±3.7 | 71±1.5 | 69±2.6 | |
| 135 | 71±2.5 | 64±5.4 | 70±1.6 | 70±2.5 | |
|
| 0 | 6.4±0.2 | 7.4±0.51 | 6.5±0.37 | 6.7±0.4 |
| 75 | 6.5±0.24 | 6.9±0.55 | 6.5±0.27 | 7.6±0.8 | |
| 135 | 7.1±0.42 | 6.7±0.27 | 6.9±0.25 | 6.8±0.2 | |
|
| 0 | 300±14.32 | 314±13.92 | 328±9.19 | 295±14.04 |
| 75 | 277±17.84 | 281±18.44 | 298±12.29 | 273±11.22 | |
| 135 | 269±31.4 | 216±36.12 | 332±15.87 | 272±11.69 |
ANOVA P<0.05:
S vs. S+B or T vs. T+B.
Data are expressed as mean ± SEM.
Lactate pharmacokinetics.
| T |
| |
|
| 1.3±0.1 | 1.3±0.1 |
|
| 13.3±0.8 | 14.5±1.1 |
|
| 17.65±1.2 | 18.4±1.4 |
|
| 5.5±0.4 | 5.2±0.5 |
|
| 0.354±0.106 | 0.19±0.101 |
|
| 4.294±0.736 | 17.983±7.592 |
|
| −0.0589±0.038 | 0.116±0.058 |
Mann-Whitney Rank Sum Test P<0.05:
T+B vs. T.
Lacbasal, lactate concentration at baseline; Lac clearance, clearance of exogenous lactate; BLP, basal lactate production; Lac75′, lactate concentration at time 75; b, coefficient b; T ½, half time decay; c, coefficient c.
Data are expressed as mean ± SEM.
Figure 4Blood lactate and blood glucose decrease in transient lactic acid infusion group.
Decrease over time of blood lactate concentration and glycaemia in the animals with transient lactic acid infusion. Values are expressed as percentage decrease from time 75 to 135 (*P<0.05 vs. transient group).
Figure 5PFK activity.
Activity of the glycolytic enzyme phosphofructokinase (PFK) in the glycolitic muscle (ME- extensor digitorum longus) was slightly higher when bicarbonate was infused (P = 0.067). Ctrl = end of lactic acid infusion (i.e 75′ after the start of acid load).